Progress in Pharmacotherapy for Obesity.

Yanovski, Susan Z; Yanovski, Jack A

Yanovski, Susan Z; Yanovski, Jack A.

Yanovski SZ; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Yanovski JA; Section on Growth and Obesity, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.

JAMA ; 326(2): 129-130, 2021 07 13.

Article in English | MEDLINE | ID: covidwho-1328581

Subject(s)

Anti-Obesity Agents/therapeutic use; Gastric Inhibitory Polypeptide/therapeutic use; Glucagon-Like Peptide-1 Receptor/agonists; Glucagon-Like Peptides/therapeutic use; Obesity/drug therapy; Adult; Clinical Trials, Phase III as Topic; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastric Inhibitory Polypeptide / Anti-Obesity Agents / Glucagon-Like Peptides / Glucagon-Like Peptide-1 Receptor / Obesity Type of study: Prognostic study Limits: Adult / Humans Language: English Journal: JAMA Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google